Indeed, previous findings demonstrate that HMGA1 overexpression mediates gemcitabine resistance in pancreatic adenocarcinoma cells through an Akt-dependent mechanism [6], and over-activation of Akt pathway is a poor prognostic factor in cancer [16]. The gene discussed is HMGA1; the disease is pancreatic adenocarcinoma.